This federal contract award in the amount of $97,584.97 was issued by the Food and Drug Administration (FDA) to The Ohio State University. The award is part of the OARSA CONSORTIUM and has a period of performance ending on September 30, 2017. The contract is a firm fixed-price purchase order and does not have a set-aside designation. The Ohio State University has a history of providing various goods and services to federal agencies, including coordination and support services for clinical trials...
This is a federal contract award from the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to The Ohio State University (OSU) for a study on small specialty farming produce. The contract is a firm-fixed-price purchase order with a potential value of $110,600.00. The contract was awarded on September 11, 2017 and the period of performance is through September 14, 2018. The contract does not have a set-aside designation. As a public research university, OSU has...
The Ohio State University was awarded a firm fixed price definitive contract valued at $429,098.39 by the Department of Health and Human Services' Food and Drug Administration to provide training and pilot processing laboratory facility services in Columbus, Ohio. The contract has a period of performance through March 2023 to support the FDA's Office of Training Education and Development in delivering processing technology courses. No set-aside designation was used for this award made under an...
The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a $963,253.00 firm fixed price purchase order contract to The Ohio State University for research on "Foodborne Pathogens in Small Specialty Farming Produce and Transduction of Antimicrobial Resistance Genes in Agricultural Systems." The contract, which does not have a set-aside designation, runs through September 29, 2024. As a public research university, The Ohio State University has a history...
The U.S. Food and Drug Administration (FDA) awarded a $833,004 firm-fixed-price contract to The Ohio State University to provide training facilities, qualified instructors, audiovisual support equipment, and pilot processing laboratories to deliver the FDA's Food Processing and Technology Course (FD 152). This course is part of the FDA's manufactured food curriculum for training federal, state, local, and tribal investigators/inspectors to conduct regulatory inspections. The contract has an...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $234,400.00 firm fixed price purchase order to The Ohio State University for the testing of gnotobiotic piglets. The contract has a completion date of December 31, 2022 and was awarded on July 23, 2020. The Ohio State University is a public research university that has a history of providing various goods and services to federal agencies through prime contracts and subcontracts, including...
This is a definitive, firm-fixed-price contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to The Ohio State University for the "OHIO STATE ORGANISMS & GENES STUDY." The contract, which does not have a set-aside designation, was awarded on September 30, 2018 with a potential value of $385,853.00 and a completion date of December 31, 2019. As a public research university, The Ohio State University has a history of...
This is a $1,303,695.00 Firm Fixed Price definitive contract awarded by the Food and Drug Administration (FDA) to Central State University, a historically black university in Wilberforce, Ohio. The contract is for the "Characterization of Chemical Constituents from Smokable Hemp Flower and E-Cigarette" and was awarded under the FDA's Broad Agency Announcement (BAA) for regulatory science and innovation research. The work will be performed in Wilberforce, Ohio and is not set aside for...
This is a $1,923,145.00 Firm Fixed Price Delivery Order awarded by the Food and Drug Administration (FDA) to Battelle Memorial Institute, a large nonprofit research and development organization, to investigate the effects of nicotine pouch flavors on abuse liability in smokeless tobacco users. The contract has no set-aside designation. Battelle has subcontracted work to Montrose Environmental Group, Inc. for analytical services, and to Virginia Commonwealth University for research evaluating the...
This is a firm fixed-price delivery order contract awarded by the Food and Drug Administration (FDA) to Battelle Memorial Institute, a nonprofit research and development organization, for a project titled "Can Machine Generated Nicotine Yield Predict Human Nicotine Exposure from Electronic Nicotine Delivery Systems (ENDS)?". The $2,021,201 contract has a period of performance ending on September 29, 2025. Battelle has subcontracted with Montrose Environmental Group, Inc. to provide...